These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3338981)

  • 1. Major depression, anxiety, and substance abuse in a multiple sclerosis patient: diagnosis, treatment, and outcome.
    Olivera AA; Fero D; Evans M
    J Clin Psychiatry; 1988 Feb; 49(2):78. PubMed ID: 3338981
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential diagnosis in MH settings: heed signs of substance abuse.
    Sauerland RM
    Behav Healthc Tomorrow; 2003 Oct; 12(5):36-8. PubMed ID: 14564969
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of anxiety and depression in HIV-infected patients.
    Cabaj RP
    J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):11-6. PubMed ID: 11363692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiety disorders and the emergence of sex differences in major depression.
    Breslau N; Chilcoat H; Schultz LR
    J Gend Specif Med; 1998 Dec; 1(3):33-9. PubMed ID: 11279862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
    Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiety and depression in substance abuse: clinical implications.
    Kranzler HR; Liebowitz NR
    Med Clin North Am; 1988 Jul; 72(4):867-85. PubMed ID: 3287042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Symptoms profile of mixed anxiety and depressive disorder].
    Małyszczak K; Sidorowicz S; Łaczmański T
    Psychiatr Pol; 2001; 35(5):743-53. PubMed ID: 11842606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed anxiety-depression in a 1 year follow-up study: shift to other diagnoses or remission?
    Barkow K; Heun R; Wittchen HU; Bedirhan Ustün T; Gänsicke M; Maier W
    J Affect Disord; 2004 Apr; 79(1-3):235-9. PubMed ID: 15023500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome and impact of mental disorders in primary care at 5 years.
    Jackson JL; Passamonti M; Kroenke K
    Psychosom Med; 2007 Apr; 69(3):270-6. PubMed ID: 17401055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative evaluation of substance abuse treatment IV. The effect of comorbid psychiatric diagnoses on amount of treatment, continuing care, and 1-year outcomes.
    Ouimette PC; Gima K; Moos RH; Finney JW
    Alcohol Clin Exp Res; 1999 Mar; 23(3):552-7. PubMed ID: 10195832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary depression: treatment and outcome.
    Kranzler HR
    J Clin Psychiatry; 1988 Sep; 49(9):370-1. PubMed ID: 3417625
    [No Abstract]   [Full Text] [Related]  

  • 13. Premorbid onset of psychopathology in long-term recovered anorexia nervosa.
    Deep AL; Nagy LM; Weltzin TE; Rao R; Kaye WH
    Int J Eat Disord; 1995 Apr; 17(3):291-7. PubMed ID: 7773266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.
    de Graaf R; Bijl RV; Spijker J; Beekman AT; Vollebergh WA
    Soc Psychiatry Psychiatr Epidemiol; 2003 Jan; 38(1):1-11. PubMed ID: 12563553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifetime rates of alcoholism in adults with anxiety, depression, or co-morbid depression/anxiety: a community survey of Ontario.
    Gratzer D; Levitan RD; Sheldon T; Toneatto T; Rector NA; Goering P
    J Affect Disord; 2004 Apr; 79(1-3):209-15. PubMed ID: 15023496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults.
    Christie KA; Burke JD; Regier DA; Rae DS; Boyd JH; Locke BZ
    Am J Psychiatry; 1988 Aug; 145(8):971-5. PubMed ID: 3394882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [L-5-HTP in the treatment of sleep disorders in patients with depression and anxiety states].
    Realini R; Mascetti R
    Schweiz Rundsch Med Prax; 1988 Aug; 77(34A):24-7. PubMed ID: 3187267
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychiatric disability in Ontario.
    Goering P; Lin E; Campbell D; Boyle MH; Offord DR
    Can J Psychiatry; 1996 Nov; 41(9):564-71. PubMed ID: 8946079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alexithymia and links with depression and anxiety in multiple sclerosis].
    Chahraoui K; Pinoit JM; Viegas N; Adnet J; Bonin B; Moreau T
    Rev Neurol (Paris); 2008 Mar; 164(3):242-5. PubMed ID: 18405774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous panic and depressive disorder: response to antidepressant treatments.
    Grunhaus L; Rabin D; Greden JF
    J Clin Psychiatry; 1986 Jan; 47(1):4-7. PubMed ID: 3941058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.